Jan 26 2025 11 mins 37
In this episode, we explore KarXT, a groundbreaking experimental antipsychotic that works through the cholinergic system rather than dopamine pathways. Could this novel approach revolutionize schizophrenia treatment by offering similar efficacy to current antipsychotics but without the motor side effects?
Faculty: Oliver Freudenreich, M.D.
Host: Richard Seeber, M.D.
